New research reveals that people who discontinue popular GLP-1 drugs like Mounjaro or Wegovy can put back on lost weight at a significantly accelerated pace than those who halt traditional lifestyle programs.
Research printed in a prominent health publication demonstrates that while overweight individuals frequently drop substantial amounts of their total mass while using the jabs, the weight is regained at an average rate of nearly a kilo each month after stopping.
"People using these medications must be aware of the potential of quick rebound weight gain when the treatment ends," warns expert Dr. Susan Jebb.
This pace of regain suggests a reversion to pre-treatment weight in about one and a half years.
Comparing Approaches
The analysis, which reviewed dozens of trials involving over 9,000 of patients, contrasted the effects of the injectable medications with conventional dieting.
Scientists note that people who lose weight through lifestyle changes alone generally experience a slower weight regain—approximately 0.1 kg a month—post-intervention.
Explaining the Fast Regain
Doctors propose the way of the injections is key to understanding the accelerated regain.
GLP-1 drugs imitate a natural hormone called glucagon-like peptide-1, which controls hunger.
"Long-term administration of GLP-1 levels far above than the body's typical production could lead to the system to produce less of its endogenous GLP-1, and may also reduce responsiveness to its effects," said Dr. Adam Collins, a nutrition specialist.
"Stopping of this medication results in appetite is uncontrolled, making excessive eating far more likely."
A Lifelong Condition?
Health authorities suggest the jabs for people with obesity-related medical conditions, accompanied by recommended lifestyle changes.
Many experts contend that, due to the likelihood of weight regain, the therapy is often long-term.
This perspective is echoed by drug manufacturers, who note that the findings "highlight the long-term nature of obesity," comparing it to managing conditions like high blood pressure.
User Testimonies
People who have stopped the jabs report a powerful return of appetite.
"It felt as if a switch flipping and I was suddenly extremely hungry," said one woman.
This difficulty is compounded if patients have not established sustainable dietary or behavioural modifications during therapy.
Significant Interest
Figures indicate that a significant number of people in the UK have tried weight-loss jabs in the last 12 months, with interest being substantial.
- Use is more common among females than males.
- The 40s and 50s demographic shows the greatest level of interest.
- Many obtain the medications through private prescriptions rather than public health services.
In conclusion, experts emphasize that while GLP-1 drugs are powerful tools for shedding pounds, they are not a standalone solution and maintained weight loss relies on integrated lifestyle changes.
